Our intent is to introduce a real time rapid assessment method, M-ROSE to assist the physicians for formulating accurate treatment strategies for patient with pulmonary infections. Rapid cell staining technology and a high definition microscopic imaging system are currently used to advance research in the field. The number of clinical studies on M-ROSE is relatively limited.
The biggest challenge is interpretation of M-ROSE results, which requires personnel, and trained personnel as it is difficult to visually identify pathogens and differentiate between infection and contamination. With a better understanding of pathogens causing infections in real time, physicians can avoid unnecessary broad spectrum antibiotics contributing to antibiotic resistance and as a treatment of pulmonary infections. M-ROSE is real time and highly efficient.
M-ROSE enables the microscopic identification of pathogens such as aspergillus, cryptococcus, numerous and candida. It holds significant guiding implications in sizing respiratory basic quality, distinguishing infections from non-infectious disease, discriminating, infection from contamination, as well as evaluating infection, severity, and prognose.
